We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$463B
AUM Growth
+$17.5B
Cap. Flow
-$1.61B
Cap. Flow %
-0.35%
Top 10 Hldgs %
12.49%
Holding
2,596
New
97
Increased
1,091
Reduced
793
Closed
67

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$1.3B
2
AAL icon
American Airlines Group
AAL
+$853M
3
ISRG icon
Intuitive Surgical
ISRG
+$816M
4
MS icon
Morgan Stanley
MS
+$681M
5
WYNN icon
Wynn Resorts
WYNN
+$622M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$1.4B
2
EBAY icon
eBay
EBAY
+$763M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$760M
4
AVGO icon
Broadcom
AVGO
+$757M
5
USB icon
US Bancorp
USB
+$686M

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Consumer Discretionary 13.46%
3 Financials 12.79%
4 Industrials 12.13%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRLB icon
2526
Protolabs
PRLB
$2.21B
– –
-44,000
Closed -$2.98M
PSEC icon
2527
Prospect Capital
PSEC
$1.18B
– –
-20,900
Closed -$226K
SFNC icon
2528
Simmons First National
SFNC
$3.46B
– –
-11,400
Closed -$212K
SRCE icon
2529
1st Source
SRCE
$2.13B
– –
-7,017
Closed -$205K
WINA icon
2530
Winmark
WINA
$1.26B
– –
-3,400
Closed -$257K
WW
2531
DELISTED
WW International
WW
– –
-9,800
Closed -$201K
ENLC
2532
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
– –
-10,600
Closed -$360K
MDRX
2533
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-30,100
Closed -$543K
WWE
2534
DELISTED
World Wrestling Entertainment
WWE
– –
-8,700
Closed -$251K
DRNA
2535
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-172,800
Closed -$4.88M
MCEP
2536
DELISTED
Mid-Con Energy Partners, LP
MCEP
– –
-6,553
Closed -$2.83M
CRCM
2537
DELISTED
CARE.COM, INC.
CRCM
– –
-327,300
Closed -$5.42M
ACHN
2538
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-27,400
Closed -$90K
IMPV
2539
DELISTED
Imperva, Inc.
IMPV
– –
-4,700
Closed -$262K
ENOC
2540
DELISTED
EnerNOC, Inc.
ENOC
– –
-9,000
Closed -$201K
CYNO
2541
DELISTED
Cynosure, Inc. Class A
CYNO
– –
-8,257
Closed -$242K
SZMK
2542
DELISTED
SIZMEK INC COM STK (DE)
SZMK
– –
-58,000
Closed -$617K
ESI
2543
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
– –
-8,920
Closed -$256K
MR
2544
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
– –
-1,142,841
Closed -$37M
GDP
2545
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
– –
-12,000
Closed -$190K
MCGC
2546
DELISTED
MCG CAP CORP
MCGC
– –
-46,100
Closed -$175K
RALY
2547
DELISTED
RALLY SOFTWARE DEV CORP
RALY
– –
-15,000
Closed -$201K
CTP
2548
DELISTED
CTPARTNERS EXECUTIVE SEARCH INC (DE)
CTP
– –
-277,416
Closed -$3.02M
PAL
2549
DELISTED
NORTH AMERICAN PALLADIUM LTD
PAL
– –
-2,027,670
Closed -$973K
OABC
2550
DELISTED
OMNIAMERICAN BANCORP INC COM STK (TX)
OABC
– –
-60,500
Closed -$1.38M
99 100 101
102
103

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates's Q2 2014 Portfolio in Review

As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
  • T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
  • T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
  • T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
  • T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.

Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.